cbdMD, Inc.: Akretive Holdings LLC discloses a stake of more than 5% (Schedule 13D)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Akretive Holdings LLC disclosed a stake exceeding 5% in cbdMD, Inc. through a Schedule 13D filing with the SEC (accession 0001437749-26-035032). The 13D form signals an active investor position rather than a passive one, giving Akretive potential influence over the cannabis-focused consumer products company. The exact share count and percentage were not specified in the filing headline. Investors will watch for details on Akretive's intent—whether the stake is for investment purposes or to push for strategic or governance changes—and any subsequent purchases or board engagement.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13D's report. It can get details wrong, so check the source.
Named in this story
Akretive Holdings LLC, cbdMD, Inc.